With fewer than 1 in 3 Americans with hypertension successfully controlling his or her blood pressure, medication, diet and exercise might not be enough. Now, a promising new non-drug treatment offers an additional approach.
High blood pressure was significantly decreased using a new interactive breathing device, RESPeRATE®, according to a study published in this months edition of the Journal of Clinical Hypertension.
The multi-center randomized controlled study of 149 patients, led by Dr. William J. Elliott of Rush University Medical Center, demonstrated that as little as 45 minutes of weekly self-treatment with the RESPeRATE® device significantly reduces systolic blood pressure in both medicated and non-medicated patients. The reductions were significantly greater than those observed in patients in the control group. Patients in both groups self-monitored their blood pressure with data-logging digital blood pressure monitors.
Usher syndrome: Gene therapy restores hearing and balance
25.09.2017 | Institut Pasteur
MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer
25.09.2017 | Case Western Reserve University
A warming planet
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
25.09.2017 | Power and Electrical Engineering
25.09.2017 | Health and Medicine
25.09.2017 | Physics and Astronomy